Atlas Trials

John Kirkwood

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch John Kirkwood

RecordFirmDate
Axelopran and Nivolumab in PD-1-Refractory Metastatic Melanoma (NCT07631325)John Kirkwood2026-10-31
Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma (NCT07223411)John Kirkwood2025-11-19
Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi (NCT06599619)John Kirkwood2025-02-20
Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable Melanoma (NCT04688658)John Kirkwood2021-10-06
Nivolumab, BMS-936558 in Combination with Relatlimab, BMS-986016 in Patients with Metastatic Melanoma Naïve to Prior Immunotherapy in the Metastatic Setting (NCT03743766)John Kirkwood2019-03-29

Track John Kirkwood automatically

Every clearance here is in the API, with alerts when new ones post.